Literature DB >> 10195104

Adjacent phosphorylation sites on GABAA receptor beta subunits determine regulation by cAMP-dependent protein kinase.

B J McDonald1, A Amato, C N Connolly, D Benke, S J Moss, T G Smart.   

Abstract

Activation of cAMP-dependent protein kinase (PKA) can enhance or reduce the function of neuronal GABAA receptors, the major sites of fast synaptic inhibition in the brain. This differential regulation depends on PKA-induced phosphorylation of adjacent conserved sites in the receptor beta subunits. Phosphorylation of beta 3 subunit-containing receptors at S408 and S409 enhanced the GABA-activated response, whereas selectively mutating S408 to alanine converted the potentiation into an inhibition, comparable to that of beta 1 subunits, which are phosphorylated solely on S409. These distinct modes of regulation were interconvertible between beta 1 and beta 3 subunits and depended upon the presence of S408 in either subunit. In contrast, beta 2 subunit-containing receptors were not phosphorylated or affected by PKA. Differential regulation by PKA of postsynaptic GABAA receptors containing different beta subunits may have profound effects on neuronal excitability.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10195104     DOI: 10.1038/223

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  79 in total

1.  Differential regulation of synaptic GABAA receptors by cAMP-dependent protein kinase in mouse cerebellar and olfactory bulb neurones.

Authors:  Z Nusser; W Sieghart; I Mody
Journal:  J Physiol       Date:  1999-12-01       Impact factor: 5.182

2.  Identification of amino acid residues within GABA(A) receptor beta subunits that mediate both homomeric and heteromeric receptor expression.

Authors:  P M Taylor; P Thomas; G H Gorrie; C N Connolly; T G Smart; S J Moss
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

3.  Single-channel properties of synaptic and extrasynaptic GABAA receptors suggest differential targeting of receptor subtypes.

Authors:  S G Brickley; S G Cull-Candy; M Farrant
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

4.  Constitutive endocytosis of GABAA receptors by an association with the adaptin AP2 complex modulates inhibitory synaptic currents in hippocampal neurons.

Authors:  J T Kittler; P Delmas; J N Jovanovic; D A Brown; T G Smart; S J Moss
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

5.  An initiator element mediates autologous downregulation of the human type A gamma -aminobutyric acid receptor beta 1 subunit gene.

Authors:  S J Russek; S Bandyopadhyay; D H Farb
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

6.  Positive allosteric modulation by ultraviolet irradiation on GABA(A), but not GABA(C), receptors expressed in Xenopus oocytes.

Authors:  Y Chang; Y Xie; D S Weiss
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

7.  The gamma-aminobutyric acid type A (GABAA) receptor-associated protein (GABARAP) promotes GABAA receptor clustering and modulates the channel kinetics.

Authors:  L Chen; H Wang; S Vicini; R W Olsen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

Review 8.  Regulation of GABAergic inhibition by serotonin signaling in prefrontal cortex: molecular mechanisms and functional implications.

Authors:  Zhen Yan
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.590

9.  Neonatal development of the rat visual cortex: synaptic function of GABAA receptor alpha subunits.

Authors:  Laurens W J Bosman; Thomas W Rosahl; Arjen B Brussaard
Journal:  J Physiol       Date:  2002-11-15       Impact factor: 5.182

10.  Apremilast regulates acute effects of ethanol and other GABAergic drugs via protein kinase A-dependent signaling.

Authors:  Yuri A Blednov; Cecilia M Borghese; Michael P Dugan; Swetak Pradhan; Thanvi M Thodati; Nikhita R Kichili; R Adron Harris; Robert O Messing
Journal:  Neuropharmacology       Date:  2020-07-29       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.